Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary.
Varadhachary GR, Spector Y, Abbruzzese JL, Rosenwald S, Wang H, Aharonov R, Carlson HR, Cohen D, Karanth S, Macinskas J, Lenzi R, Chajut A, Edmonston TB, Raber MN. Varadhachary GR, et al. Among authors: aharonov r. Clin Cancer Res. 2011 Jun 15;17(12):4063-70. doi: 10.1158/1078-0432.CCR-10-2599. Epub 2011 Apr 29. Clin Cancer Res. 2011. PMID: 21531815
Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary.
Pentheroudakis G, Pavlidis N, Fountzilas G, Krikelis D, Goussia A, Stoyianni A, Sanden M, St Cyr B, Yerushalmi N, Benjamin H, Meiri E, Chajut A, Rosenwald S, Aharonov R, Spector Y. Pentheroudakis G, et al. Among authors: aharonov r. Mol Cancer. 2013 Jun 10;12:57. doi: 10.1186/1476-4598-12-57. Mol Cancer. 2013. PMID: 23758919 Free PMC article.
A second-generation microRNA-based assay for diagnosing tumor tissue origin.
Meiri E, Mueller WC, Rosenwald S, Zepeniuk M, Klinke E, Edmonston TB, Werner M, Lass U, Barshack I, Feinmesser M, Huszar M, Fogt F, Ashkenazi K, Sanden M, Goren E, Dromi N, Zion O, Burnstein I, Chajut A, Spector Y, Aharonov R. Meiri E, et al. Among authors: aharonov r. Oncologist. 2012;17(6):801-12. doi: 10.1634/theoncologist.2011-0466. Epub 2012 May 22. Oncologist. 2012. PMID: 22618571 Free PMC article.
MicroRNAs accurately identify cancer tissue origin.
Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, Lebanony D, Goren Y, Silberschein E, Targan N, Ben-Ari A, Gilad S, Sion-Vardy N, Tobar A, Feinmesser M, Kharenko O, Nativ O, Nass D, Perelman M, Yosepovich A, Shalmon B, Polak-Charcon S, Fridman E, Avniel A, Bentwich I, Bentwich Z, Cohen D, Chajut A, Barshack I. Rosenfeld N, et al. Among authors: aharonov r. Nat Biotechnol. 2008 Apr;26(4):462-9. doi: 10.1038/nbt1392. Epub 2008 Mar 23. Nat Biotechnol. 2008. PMID: 18362881
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M. Lebanony D, et al. Among authors: aharonov r. J Clin Oncol. 2009 Apr 20;27(12):2030-7. doi: 10.1200/JCO.2008.19.4134. Epub 2009 Mar 9. J Clin Oncol. 2009. PMID: 19273703
Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin.
Rosenwald S, Gilad S, Benjamin S, Lebanony D, Dromi N, Faerman A, Benjamin H, Tamir R, Ezagouri M, Goren E, Barshack I, Nass D, Tobar A, Feinmesser M, Rosenfeld N, Leizerman I, Ashkenazi K, Spector Y, Chajut A, Aharonov R. Rosenwald S, et al. Among authors: aharonov r. Mod Pathol. 2010 Jun;23(6):814-23. doi: 10.1038/modpathol.2010.57. Epub 2010 Mar 26. Mod Pathol. 2010. PMID: 20348879 Free article.
A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma.
Benjamin H, Lebanony D, Rosenwald S, Cohen L, Gibori H, Barabash N, Ashkenazi K, Goren E, Meiri E, Morgenstern S, Perelman M, Barshack I, Goren Y, Edmonston TB, Chajut A, Aharonov R, Bentwich Z, Rosenfeld N, Cohen D. Benjamin H, et al. Among authors: aharonov r. J Mol Diagn. 2010 Nov;12(6):771-9. doi: 10.2353/jmoldx.2010.090169. Epub 2010 Sep 23. J Mol Diagn. 2010. PMID: 20864637 Free PMC article.
Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.
Pentheroudakis G, Spector Y, Krikelis D, Kotoula V, Meiri E, Malamou-Mitsi V, Fountzilas G, Sanden M, Pavlidis N, Benjamin H, Aharonov R. Pentheroudakis G, et al. Among authors: aharonov r. Clin Exp Metastasis. 2013 Apr;30(4):431-9. doi: 10.1007/s10585-012-9548-3. Epub 2012 Nov 4. Clin Exp Metastasis. 2013. PMID: 23124598 Clinical Trial.
hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma.
Pass HI, Goparaju C, Ivanov S, Donington J, Carbone M, Hoshen M, Cohen D, Chajut A, Rosenwald S, Dan H, Benjamin S, Aharonov R. Pass HI, et al. Among authors: aharonov r. Cancer Res. 2010 Mar 1;70(5):1916-24. doi: 10.1158/0008-5472.CAN-09-3993. Epub 2010 Feb 16. Cancer Res. 2010. PMID: 20160038 Free PMC article.
31 results